Vycor Medical, Inc.
VYCO
$0.068
$0.00324.94%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -498.00% | 67.32% | 67.13% | -79.38% | -175.88% |
| Total Depreciation and Amortization | 0.00% | 0.64% | 3.31% | -0.66% | 0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -100.00% | 231.82% | -21.43% | -9.68% |
| Change in Net Operating Assets | -37.86% | 745.26% | -88.30% | 327.37% | 126.21% |
| Cash from Operations | -87.79% | 4,426.32% | -65.45% | 136.91% | -204.93% |
| Capital Expenditure | -- | -- | -- | -68.57% | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -266.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | 111.86% | -47.50% | -1,433.33% |
| Total Debt Issued | -- | -- | -- | -18.38% | 3,611.76% |
| Total Debt Repaid | -165.09% | 33.75% | 74.56% | -119.93% | -172.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 410.38% | 33.75% | -40.35% | -133.04% | 492.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.20% | 662.69% | -13.56% | -175.16% | 180.36% |
